These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37271160)

  • 1. Barriers and facilitators to HIV pre-exposure prophylaxis for cisgender and transgender women in the UK.
    Whelan I; Strachan S; Apea V; Orkin C; Paparini S
    Lancet HIV; 2023 Jul; 10(7):e472-e481. PubMed ID: 37271160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the U.S.: A Narrative Review of the Literature.
    Baldwin A; Light B; Allison WE
    Arch Sex Behav; 2021 May; 50(4):1713-1728. PubMed ID: 34075504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California.
    Ogunbajo A; Storholm ED; Ober AJ; Bogart LM; Reback CJ; Flynn R; Lyman P; Morris S
    AIDS Behav; 2021 Jul; 25(7):2301-2315. PubMed ID: 33515132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk perception, safer sex practices and PrEP enthusiasm: barriers and facilitators to oral HIV pre-exposure prophylaxis in Black African and Black Caribbean women in the UK.
    Nakasone SE; Young I; Estcourt CS; Calliste J; Flowers P; Ridgway J; Shahmanesh M
    Sex Transm Infect; 2020 Aug; 96(5):349-354. PubMed ID: 32532928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
    Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.
    Rael CT; Martinez M; Giguere R; Bockting W; MacCrate C; Mellman W; Valente P; Greene GJ; Sherman S; Footer KHA; D'Aquila RT; Carballo-Diéguez A
    AIDS Behav; 2018 Nov; 22(11):3627-3636. PubMed ID: 29589137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
    Sevelius JM; Keatley J; Calma N; Arnold E
    Glob Public Health; 2016; 11(7-8):1060-75. PubMed ID: 26963756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.
    Shorrock F; Alvarenga A; Hailey-Fair K; Vickroy W; Cos T; Kwait J; Trexler C; Wirtz AL; Galai N; Beyrer C; Celentano D; Arrington-Sanders R
    AIDS Patient Care STDS; 2022 May; 36(5):194-203. PubMed ID: 35507322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
    Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
    BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrEP Stigma and logistical barriers remain significant challenges in curtailing HIV transmission among Black and Hispanic/Latinx cisgender sexual minority men and transgender women in the US.
    Watson RJ; Chang CJ; Feinstein BA; Moody RL; Caba A; Eaton LA
    AIDS Care; 2022 Nov; 34(11):1465-1472. PubMed ID: 35848490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
    Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
    AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitators of PrEP Persistence among Black and Latinx Transgender Women in a PrEP Demonstration Project in Southern California.
    Storholm ED; Ogunbajo A; Nacht CL; Opalo C; Horvath KJ; Lyman P; Flynn R; Reback CJ; Blumenthal J; Moore DJ; Bolan R; Morris S
    Behav Med; 2024; 50(1):63-74. PubMed ID: 35993278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the Awareness, Acceptability, and Adoption of Conventional and non-conventional Forms of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among jail-involved Black Sexual Minority men (BSMM) and Black Transgender Women (BTW) in Two Diverse US Cities.
    Jones MD; Jones K; Almirol E; Payne G; Graves B; Schneider JA; Rijos D; Zawitz C; Zimmerman R; Seal DW; Brewer R; DrPH RB
    AIDS Behav; 2023 Apr; 27(4):1304-1313. PubMed ID: 36264406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "PrEP"ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women.
    Pasipanodya EC; Stockman J; Phuntsog T; Morris S; Psaros C; Landovitz R; Amico KR; Moore DJ; Blumenthal J
    BMC Womens Health; 2021 May; 21(1):220. PubMed ID: 34034719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEP Among Black and White Men and Transgender Women Who Have Sex with Men.
    Eaton LA; Kalichman SC; Price D; Finneran S; Allen A; Maksut J
    AIDS Behav; 2017 May; 21(5):1236-1246. PubMed ID: 28108878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse contexts and social factors among young cisgender men and transgender women who sell or trade sex in Bangkok and Pattaya, Thailand: formative research for a PrEP program implementation study.
    Truong JM; Chemnasiri T; Wirtz AL; Mon SHH; Varangrat A; Decker M; Janyam S; Linjongrat D; Sirivongrangson P; Hickey AC; Weir BW; Beyrer C;
    AIDS Care; 2022 Nov; 34(11):1443-1451. PubMed ID: 35473429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention.
    Walters SM; Platt J; Anakaraonye A; Golub SA; Cunningham CO; Norton BL; Sevelius JM; Blackstock OJ
    AIDS Behav; 2021 Dec; 25(12):3987-3999. PubMed ID: 34138377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
    Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
    Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and motivators to pre-exposure prophylaxis uptake among Black and Latina transgender women in Los Angeles: perspectives of current PrEP users.
    Nieto O; Fehrenbacher AE; Cabral A; Landrian A; Brooks RA
    AIDS Care; 2021 Feb; 33(2):244-252. PubMed ID: 32449399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.